lisdexamfetamine dimesylate
Generic: lisdexamfetamine dimesylate
Labeler: camber pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
lisdexamfetamine dimesylate
Generic Name
lisdexamfetamine dimesylate
Labeler
camber pharmaceuticals, inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
lisdexamfetamine dimesylate 60 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
31722-355
Product ID
31722-355_c797bf2e-e9b6-4f7f-b12c-c514667107f0
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA217442
DEA Schedule
cii
Listing Expiration
2026-12-31
Marketing Start
2024-09-09
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
31722355
Hyphenated Format
31722-355
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lisdexamfetamine dimesylate (source: ndc)
Generic Name
lisdexamfetamine dimesylate (source: ndc)
Application Number
ANDA217442 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 60 mg/1
Packaging
- 100 CAPSULE in 1 BOTTLE (31722-355-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c797bf2e-e9b6-4f7f-b12c-c514667107f0", "openfda": {"upc": ["0331722353014", "0331722352017", "0331722356015", "0331722351010", "0331722354011", "0331722350013", "0331722355018"], "unii": ["SJT761GEGS"], "rxcui": ["854830", "854834", "854838", "854842", "854846", "854850", "1593856"], "spl_set_id": ["20baa61e-be0b-41a3-a896-29e8ce8c4799"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (31722-355-01)", "package_ndc": "31722-355-01", "marketing_start_date": "20240909"}], "brand_name": "LISDEXAMFETAMINE DIMESYLATE", "product_id": "31722-355_c797bf2e-e9b6-4f7f-b12c-c514667107f0", "dosage_form": "CAPSULE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "31722-355", "dea_schedule": "CII", "generic_name": "Lisdexamfetamine dimesylate", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LISDEXAMFETAMINE DIMESYLATE", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "60 mg/1"}], "application_number": "ANDA217442", "marketing_category": "ANDA", "marketing_start_date": "20240909", "listing_expiration_date": "20261231"}